Clinical Interventions for Alcohol Use Disorder Pharmacological tapering support for alcohol use disorder targets acetaldehyde accumulation, reactive oxygen species generation, and hepatic injury rather than metabolic rate itself
Cyclosporiasis isn't typically fatal, and people's bodies seem to get better at fighting it off in places where the parasite is more common, including tropical and subtropical regions
Going 'too high, too fast' is a recipe for discomfort and failure
doi: 10.1002/oby.24274 42 OldVJDaviesMJPapamargaritisDChoudharyPWatsonEL
One explanation could be the formation of a polymeric barrier consisting of chains of -d-mannuronic (M) and -l-guluronic (G) acids linked by glycosidic bonds 14, monomers that are sequentially distributed in each repetitive subunit (Loureiro Dos Santos, 2017)
Early-phase clinical trials have explored synthetic FGF21 variants for their potential to reduce liver fat and improve metabolic health, though these remain in development and are not clinically available